25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA, PA
Reports Second Quarter 2026 Financial Results and Business Updates
Chad Cowan, Ph.D. Continues as Chief Scientific Officer at Reduced Salary
Authorized Shares Amendment Approved at 2026 Annual Meeting
Investor Presentation
Reports First Quarter Financial Results and Business Updates
Annual Report to Security Holders
Century Therapeutics Files New Shelf Registration Statement and Prospectus Su...
Reports Full Year 2025 Financial Results and Business Updates
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload
Amended Notice of Proposed Sale of Securities